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Glioblastoma multiforme (GBM) is a devastating disease and the most lethal of
adult brain tumors. Treatment is based on surgery, radiotherapy and
chemotherapy by oral temozolomide (TMZ), which is the most potent
chemotherapy agent for the treatment of GBM. Despite TMZ efficiency, the
prognosis of these tumors remains poor. This is because of inherent or acquired
resistance of glioma tumor cells to TMZ. This resistance is caused by DNA repair
enzyme activity, overexpression of epidermal growth factor receptor (EGFR),
galectin-1, murine double minute 2 (Mdm2), p53 and phosphatase and tensin
homolog (PTEN) mutations. Many strategies to overcome this resistance have been
developed. In this review, we will describe the main mechanisms of GBM
resistance to TMZ and different strategies developed to reverse the phenotype of
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